Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled date : 2020 - 12 - 09 save search
Redfin to Present at Piper Sandler P.S. It's Friday Series: The Future of Home & Housing
Published: 2020-12-09 (Crawled : 23:12) - prnewswire.com
RDFN 4 | $5.2 -2.07% -2.12% 4.9M
|
Finance
|
| O: -0.41%
H: 5.76%
C: 5.16%
positive xipere
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 30, 2020
Published: 2020-12-09 (Crawled : 21:06) - globenewswire.com
NDAQ | $60.35 0.47% 0.46% 3.1M
|
Finance
|
| O: -0.28%
H: 0.49%
C: -0.6%
positive nasdaq
Top-line Final Data from Cantrixil Phase I Study Confirms Prior Positive Efficacy and Safety Signals
Published: 2020-12-09 (Crawled : 20:01) - biospace.com/
KZIA | $0.379 9.47% 8.65% 300K
|
Health Technology
|
| O: 1.58%
H: 4.66%
C: -3.59%
positive topline
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer
Published: 2020-12-09 (Crawled : 20:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -2.94%
breast cancer cancer test positive therapy results
Xenetic Biosciences, Inc. Announces Positive Data from Partner’s Pivotal Phase 3 Clinical Trial Utilizing PolyXen(R) Platform Technology
Published: 2020-12-09 (Crawled : 17:00) - biospace.com/
XBIO | $4.14 7.32% 770
|
Health Technology
|
| O: 258.33%
H: 51.16%
C: -18.09%
positive phase 3 trial
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18
Published: 2020-12-09 (Crawled : 16:00) - biospace.com/
INO 3 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 0.08%
H: 0.67%
C: -4.43%
positive cancer treatment phase 2
Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic Dermatitis
Published: 2020-12-09 (Crawled : 12:04) - globenewswire.com
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 7.06%
H: 35.6%
C: 14.26%
positive dermatitis trial topline atopic dermatitis phase 1b phase 2b bioscience
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.